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Aims:Right ventricular (RV) function is considered an independent predictor ofmortality anddevelopment of heart
failure (HF) in patients with left ventricle dysfunction following myocardial infarction (MI). The functional and
molecular mechanisms that may explain the RV dysfunction are still poorly understood. Our study was conducted
to investigate RV contractility and the myocardium protein involved in the calcium handling following MI in rats.
Main methods:MI was surgically induced in male Wistar rats to create transmural infarctions involving 40–60% of
the left ventricle surface. Infarcted rats were divided into two groups: those that presented classical signs of
congestive heart failure (HF group) and those that did not (INF group), and compared to control animals (Sham).
RV contractility was studied using isometric contraction in isolated strips and isovolumetric pressure in isolated
heart.
Key ﬁndings: Inotropic responses in RV strips were preserved in the INF group but were reduced in the HF group
(3.75 mM Ca2+ treatment: Sham = 163 ± 18; INF = 148 ± 19; HF = 68 ± 11 g/g*; *p b 0.05; 5 × 10−5 M
isoproterenol: Sham= 151± 15, INF= 134± 17, HF= 52± 7 g/g*; *p b 0.05). An increase in SERCA-2a protein
expression in the RV was observed in the INF group but not in the HF group, which could explain the preserved
inotropic response in these animals.
Signiﬁcance: Increased SERCA-2a protein expression may play a role in the preservation of RV function post-MI.
Therefore, therapeutic strategies that attempt to increase SERCA protein expression levels may be useful for the
treatment of HF.© 2015 Elsevier Inc. All rights reserved.Introduction
Left ventricle (LV) tissue loss after myocardial infarction (MI) can
cause an increase in LV ﬁlling pressure, which triggers a compensatory
hypertrophy of this chamber, followed by progressive dysfunction and
consequently heart failure (HF). The increase in left ventricular end-
diastolic pressure (LVEDP) following MI also causes right ventricular
(RV) remodeling, most likely due to pulmonary hypertension [20,21,
31]. Indeed, it has recently proposed that RV dysfunction is a reliable
independent predictor of mortality and development of HF in patients
with known LV dysfunction following MI [2,3,34]. In addition, it seems
that the degree of RV dysfunction is not linearly correlated with LV
infarct size. Thus, it is important to study the mechanisms involved in
right ventricular dysfunction after acute left ventricle MI [8,17,25,29].
Furthermore, it is well described that in HF there are abnormalities in
LV intracellular calcium homeostasis, which are caused by deﬁcienciesFisiológicas, Centro de Ciências
. Marechal Campos 1468, CEP
: +55 27 3335 7328.
.in SR Ca2+ load. These deﬁciencies are linked to decreased SERCA-2a
function, changes in the expression of Na+–Ca2+ exchanger (NCX),
phospholamban (PLB), phosphorylated phospholamban (pPLB) and
altered ryanodine-receptor (RYR) function [33]. However, it remains
unclear whether RV dysfunction is associated with changes in the
expression of these proteins.
The aim of this study was to evaluate if RV contractility and function
are affected in rats that developed or not HF after 8weeks of left-sideMI
and also look if the molecular mechanisms involved in Ca2+ regulation
could participate in this process.
Methods
Animal model and experimental infarction
Infarction was induced in male Wistar rats weighing between 200
and 230 g. The procedure was performed according to previously
described methods [21,29]. Brieﬂy, the rats were anesthetized with
ketamine (50 mg·kg−1) and xylazine (10 mg·kg−1) and underwent
left lateral thoracotomy between the fourth and ﬁfth intercostal spaces.
Following exteriorization of the heart, the left atrium was pushed aside
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tween the exit point of the pulmonary artery and left atrium. Next, the
heart was returned to the thorax and the incision was closed with 1.0
cotton sutures. The procedure was performed to induce transmural
infarction between 40–60% of the left ventricular surface without
damaging the interventricular septum. Weight-matched rats were
used as controls, and they underwent all surgical steps with the excep-
tion of coronary ligation. After a recovery period, the animals were kept
in collective cages with free access to food and water. The care and use
of the laboratory animals were performed in accordance with NIH
guidelines and all procedures were approved by the animal ethics com-
mittee (experimental protocol 005/2007).
Hemodynamic measurement
After 8 weeks, the post-MI rats were anesthetized with urethane
(1.2 g·kg−1 ip.). Next, the left jugular vein and left carotid artery were
carefully isolated to avoid damage to any surrounding nerves. A taper-
ending polyethylene cannula (PE 50) ﬁlled with heparinized saline
(100 U/ml)was inserted into the left common carotid artery tomeasure
the blood pressure (BP) and heart rate (HR) and was then inserted into
the left ventricle tomeasure the left ventricular systolic pressure (LVSP)
and left ventricle end diastolic pressure (LVEDP), as well as their ﬁrst
derivatives (+dP/dt and−dP/dt, respectively). Another catheter was
inserted into the right ventricle near the jugular vein to measure the
right ventricular systolic pressure (RVSP) and right ventricle end
diastolic pressure (RVEDP) as well as the positive (+dP/dt) and nega-
tive (−dP/dt) rates of pressure development. Arterial and ventricular
pressures were measured by connecting the catheter to a pressure
transducer (TSD 104A, Biopac System, Inc., USA) coupled to an MP100
ampliﬁer and an acquisition system (MP 100 Biopac Systems, Inc., CA,
USA) to determine the real-time pressure and HR recordings, as well
as for subsequent analyses.
Animal classiﬁcation
Infarcted rats were considered to have HF when the following
criteria weremet: Lung/BW≥ Lung/BWSham;+ 2 SD (Lungwetweight;
BW = body weight; SD = standard deviation); RV hypertrophy was
proportional to Lung/BW7,12; LVEDP N 15 mm Hg [25] and with con-
comitant reductions in the LV contractility and relaxation index. Forty
percent of all infarcted rats met the above criteria for HF (HF group),
whereas the other rats presented no signs of heart failure (INF group).
Preparation of RV strips
Following hemodynamic measurement, the animals were sacriﬁced
and their thoraxes were opened. The heart was rapidly excised and
perfused through the aortic stump to allow for precise dissection of
RV strips.
After dissection, the RV strip preparations were perfused at 30 °C
with a nutrient solution (120 mM NaCl, 5.4 mM KCl, 1.25 mM CaCl2,
1.2 mM MgCl2, 2 mM NaH2PO4, 1.2 mM Na2SO4, 27 mM NaHCO3 and
11mMglucose) that was gasiﬁed with 5% CO2 and 95% O2. The muscles
were attached to an isometric transducer and allowed to stabilize for
30–40 min under the new environmental conditions. The muscles
were stretched to Lmax (i.e., the optimal length for contraction) and
stimulated at 0.5 Hz, which was performed using a pair of platinum
electrodes placed in parallel to the length of the muscle bulk. Force
was measured using an isometric force transducer (TSD125 — Byopac
Systems, Inc., CA) and recorded using a digital data acquisition system
and software program (MP100 Byopac Systems, Inc., CA). Preparations
were analyzed to test the following: (1) post-rest potentiation,
(2) inotropic response to calcium and (3) response to isoproterenol.
Post-rest potentiation was used to assess the function of the sarco-
plasmic reticulum (SR). The force generated during the contraction ofcardiac muscle can be altered in response to changes in heart rate and
rhythm. In cardiacmuscle, the contractions that occur after short pauses
are potentiated. In rat cardiac muscle in particular, post-rest contrac-
tions increase in force as the rest period increases [22]. In general,
post-rest contractions are affected by pause duration and intracellular
calcium levels, and the SR is more important for post-rest contractions
than for steady-state contractions. Pause intervals of various durations
(15, 30, 60 and 120 s) were tested, and the results are presented as
the relative potentiation values (the amplitude of post-rest contractions
divided by steady-state contractions) to normalize the data from differ-
ent preparations. The inotropic response to calcium was assessed by
varying the concentration of extracellular Ca2+ (0.62, 1.25, 2.5 and
3.75 mM) within the perfusion ﬂuid. Next, the preparations were
washed and stabilized at a calcium concentration of 0.62 mM and
the positive inotropic effects produced by cumulative isoproterenol
concentrations (5.10−9 to 5.10−5 M within the perfusion ﬂuid)
were analyzed. The force of contraction was normalized to the wet
weight of the RV strips and values are expressed as grams of generated
force/gram tissue. The amount of time to reach peak tension following
isoproterenol treatment was also measured and used as an additional
index of responsiveness.
Isolated heart study
Hearts were excised and retrogradely perfused using the
Langendorff technique to study isolated RV function. Brieﬂy, following
thoracotomy, all vessels above the aortic arch were occluded with
nylon thread. Subsequently, the heart and lungs were removed and
connected to the analysis system. Following perfusion, the lungs and
atria were removed. The hearts were paced throughout the protocol
at 200 beats min−1 and were immersed in a water-jacketed organ
chamber at 33.5 °C in a solution containing 120 mM NaCl, 5.4 mM
KCl, 1.25 mM CaCl2, 1.2 mM MgCl2, 24 mM NaHCO3, 1.2 mM NaSO4,
2 mM NaH2PO4 2 and 11 mM glucose and continuously perfused
with gas (95% O2 and 5% CO2, pH 7.4). During equilibration, the hearts
were loaded with an initial balloon volume yielding an RV end-
diastolic pressure (RVEDP) of 0–5mmHg. The balloon was connected
to a pressure transducer (Statham P23AA) coupled to an MP100
ampliﬁer and acquisition system (MP 100 Biopac Systems, Inc., CA)
to record systolic and diastolic pressures as well as coronary perfusion
pressure. The balloonwas also coupled to awater-ﬁlled syringe (1ml)
via a catheter (PE 50) to control the ventricular diastolic pressure
using changes in balloon volume. To characterize the effects of infarc-
tion on RV mechanical function, isovolumetric systolic pressure
(RVSP, +dP/dt and −dP/dt) was evaluated using the following
procedures. Using a water-ﬁlled syringe, RV balloon volume was in-
creased in steps of 5 mm \Hg until an RVEDP of 30 mm Hg was
reached. The preparation was maintained under perfusion with con-
stant ﬂow (10 ml/min) of Krebs solution (1.25 mM Ca+2). Under
steady-state conditions, the responses were measured by increasing
Ca2+ concentrations (0.62 mM, 1.25 mM, 1.87 mM, 2.5 mM and
3.12 mM). RV diastolic pressure was maintained in 5 mm Hg. In order
to analyze inotropic response, a single dose of isoproterenol (Sigma, St
Louis, MO, USA) (10 μM) was administered to evaluate the β-
adrenoreceptor response.
Infarct size measurement
Infarct size was determined as previously described [23,27]. The
hearts were separated, weighted and ﬁxed in 10% buffered formalin
for histological quantiﬁcation. The LV was cut into three transverse sec-
tions: apex, middle ring (~3 mm), and base. Five-micrometer sections
were cut from the middle ring at 100-μm intervals and stained with
picrosirius red. Infarct perimeter (fraction of the infarcted LV) was cal-
culated as the average of the perimeter from all slices and is expressed
Table 2
Hemodynamic parameters.
Sham (n= 9) INF(n= 9) HF(n= 9)
HR (bpm) 291 ± 15 297 ± 17 312 ± 12
Infarct size (%) 55.8 ± 4.1 56 ± 2.2
SBP (mm Hg) 106 ± 5.9 105 ± 3.5 111 ± 2.4
DBP (mm Hg) 69 ± 5.5 70 ± 3.1 79 ± 1.4
MBP (mm Hg) 84 ± 5.5 85 ± 3.3 93 ± 1.8
LVSP (mm Hg) 112 ± 3 116 ± 4 120 ± 3
LVEDP (mm Hg) 5.2 ± 0.5 7.5 ± 0.7 16 ± 2.5⁎,#
LV +dP/dt (mm Hg s−1) 5103 ± 298 5120 ± 215 4098 ± 231⁎,#
LV –dP/dt (mm Hg s−1) 4683 ± 327 3971 ± 132 3184 ± 185⁎,#
RVSP (mm Hg) 28 ± 15 31 ± 2.6 48 ± 2.2⁎,#
RVEDP (mm Hg) 1.9 ± 0.3 1.2 ± 0.4 4.5 ± 0.8⁎,#
RV dP/dt+ (mm Hg) 1287 ± 155 1192 ± 165 2046 ± 226⁎,#
RV dP/dt− (mm Hg) 1039 ± 95 1239 ± 156 1807 ± 84⁎,#
Changes in systolic (SBP), diastolic (DBP) and mean blood pressures (MBP), heart rate
(HR), left and right ventricle systolic pressures (LVSP and RVSP, respectively), left and
right ventricle end diastolic pressures (LVEDP and RVEDP, respectively) and in positive
(dP/dt+) and negative ﬁrst time derivatives (dP/dt−) from Sham, infarcted without
heart failure (INF) and with heart failure (HF) rats. n—Number of animals used. Results
are expressed as the mean ± SEM values. Differences were analyzed using one-way
ANOVA followed by post hoc Bonferroni tests. Infarct size (%) was not different between
groups. (unpaired Student t-test).
⁎ p b 0.05 compared to Sham.
# p b 0.05 compared to INF.
26 A.A. Fernandes et al. / Life Sciences 124 (2015) 24–30as a percentage of length. Only rats with moderate to large infarcts
(40–60%) were included in the study.
Western Blotting analysis of SERCA, NCX, PLB and phosphorylated PLB
Proteins from homogenized RV tissue (50 μg) were separated using
7.5% or 15% SDS-PAGE. The proteins were transferred to nitrocellulose
membranes, blocked and incubated with one of the following primary
antibodies: mouse monoclonal anti-SERCA-2a (1:1000; Afﬁnity
BioReagents, CO, USA), mouse monoclonal anti-NCX (1:200; Abcam
Cambridge, MA, USA), mouse monoclonal anti-PLB (0.5 μg/ml; Afﬁnity
BioReagents, CO, USA) and rabbit polyclonal anti-PLB phospho-Ser16
(1:5000; Badrilla, Leeds, UK). After washing, themembraneswere incu-
batedwith either anti-mouse or anti-rabbit (1:5000, StressGen, Victoria,
Canada) immunoglobulin antibodies conjugated to horseradish peroxi-
dase. The membranes were then washed, and the immunocomplexes
were detected using an enhanced horseradish peroxidase/luminal
chemiluminescence system (ECL Plus; Amersham International, Little
Chalfont, UK) and exposed on ﬁlm (Hyperﬁlm ECL International).
Signals were quantiﬁed using the Image J V1.56 computer program
(National Institutes of Health). The same membranes were then used
to determine GAPDH expression using a mouse monoclonal antibody
(1:5000; Abcam Cambridge, MA, USA).
Data analysis
Data are reported as themean± SEM values. Comparisons between
infarct sizes were performed using the Student t-test for unpaired data.
One-way ANOVA test was used to evaluate hemodynamic, weight and
protein-expression data. Two-way ANOVA test was used to analyze
differences in the dose–response curves and post-rest potentiations
between the different groups.When signiﬁcant differenceswere identi-
ﬁed, subsequent analyses using Bonferroni post-hoc tests were per-
formed. Values of p b 0.05were considered to be statistically signiﬁcant.
Results
Hemodynamic evaluation and infarct size
Themean scar size was 55.8± 4.1% in the INF group and 56± 2.2%
in the HF group (Table 2, Fig. 4), remaining within the desired limits
described above of 40–60%. Right ventricle weight and lung weight
(both normalized to body weight) were signiﬁcantly increased in
the HF group (Table 1). As expected, LVEDP was signiﬁcantly in-
creased and positive and negative dP/dt were reduced in the HF
group compared with the INF and Sham groups (Table 2), characteriz-
ing cardiac dysfunction. The average values for both RV systolic and
end diastolic pressures (RVSP and RVEDP) were signiﬁcantly higherTable 1
Ponderal data.
Sham (n= 9) INF (n= 9) HF (n= 9)
BW (g) 350 ± 10 381 ± 15 339 ± 25
LV (mg) 0.59 ± 0.02 0.74 ± 0.04 0.72 ± 0.06
LV/BW (mg g−1) 1.74 ± 0.06 1.89 ± 0.07 2.08 ± 0.14⁎
RV (mg) 0.17 ± 0.01 0.21 ± 0.01 0.39 ± 0.03⁎,#
RV/BW (mg g−1) 0.55 ± 0.04 0.59 ± 0.03 1.21 ± 0.1⁎,#
Lung/BW (mg g−1) 4.95 ± 0.2 5.1 ± 0.5 7.59 ± 0.1⁎,#
BW=bodyweight; LV= left ventricleweight; RV= right ventricleweight; LV/BW= left
ventricle to bodyweight ratio; RV/BW=right ventricle to bodyweight ratio; Lung/BW;=
lung to bodyweight ratio from Sham, infarcted without heart failure (INF) and with heart
failure (HF) rats. n—Number of animals used. Results are expressed as the mean ± SEM
values. Differences were analyzed using one-way ANOVA followed by post-hoc of
Bonferroni tests.
⁎ p b 0.05 compared to Sham.
# p b 0.05 compared to INF.in the HF group 8 weeks post-MI (Table 2). Although positive dP/dt
values in the RV were not different among the groups, the negative
dP/dt values in this chamber were higher in the HF group compared
with the other groups.
Contractility study
Contractility in RV strips was evaluated by analyzing post-rest po-
tentiation and by varying the concentration of extracellular Ca2+ and
isoproterenol (Fig. 1). The inotropic response was preserved in RV
strips from the INF group, whereas this response was impaired in
strips from the HF group under all tested conditions (Fig. 1A, B and
C).We can conclude that the contractility of RV ﬁbers was not affected
when infarction of moderate size does not develop ventricular
dysfunction.
RV performance was also analyzed in isolated hearts using the
Frank–Starling curves, by changing the concentrations of extracellular
Ca2+ as well as by exposing the hearts to 10 μM of isoproterenol
(Fig. 2). As expected, all groups showed a positive inotropic response
to increased extracellular Ca2+ concentrations (0.62, 1.25, 1.87, 2.5
and 3.12 mM) as well as increased diastolic pressure, as shown in
Fig. 2 A and B. While, HF group showed smaller increases in RVSP com-
pared with the other groups at all diastolic pressure values, the INF
group presented higher positive inotropic responses at lower diastolic
pressures (0–10 mm Hg) and calcium concentrations (0.62 at
1.25 mM). However, at higher diastolic pressures and calcium concen-
trations, the INF group also showed a reduction in RVSP response
when compared with the Sham group. The positive inotropic responses
evoked by 10 μM isoproterenol are shown in Fig. 2 C. Isoproterenol in-
duced a smaller response in the HF group compared with the INF and
Shamgroups. Taken together, it seems that the overall RV basal function
of animals from INF group are in the normal patterns but when this
chamber is submitted to stress conditions the contractility response is
reduced showing a smaller cardiac function reserve. As expected
the RV contractility and overall function are affected in animals
that developed HF with a moderate infarct size.
Western Blotting analyses
Intracellular calcium homeostasismainly depends upon SERCA-2a,
PLB and NCX. Therefore, we analyzed the expression of these proteins
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Fig. 1. Isometric force (g/g) in RV strips measured in (A) different extracellular CaCl2 (0.62, 1.25, 2.5 and 3.75 mM) concentrations; (B) different (5.10−9 to 5.10−5 M) concentrations and
(C) relative post-rest potentiation in 15, 30, 60 and 120 s. *p b 0.05 vs. Sham; #p b 0.05 vs. INF. Results are presented as mean ± SEM values. Differences were analyzed using two-way
ANOVA followed by post-hoc of Bonferroni tests.
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in the right ventricle of the INF group were signiﬁcantly higher than
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Fig. 3. A densitometry analysis of theWestern blot data for (A) SERCA-2a, (B) Na-Ca exchange (NCX), (C) SERCA-2a/NCX ratio, (D) phospholamban (PLB), (E) phosphorylated phospho-
lamban (pPLB-Ser16) and (F) PLB/pPLB-Ser16 ratio from RV heart samples from the Sham, infarcted (INF) and infarcted with heart failure sign (HF) groups. Representative blots are
shown. *p b 0.05 vs. Sham; +p,b0.05 vs. HF. Results are expressed as the mean ± SEM values. Differences were analyzed using one-way ANOVA followed by post hoc Bonferroni tests.
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prolonged pressure overload [7].
The expression of NCX was not signiﬁcantly different between
groups (Fig. 3 B). In addition, the SERCA-2a/NCX ratio was 2.4-fold
greater in the INF group when compared with that in the HF group
(Fig. 3 C), which means an increase in SERCA-2a activity in these an-
imals. Fig. 3 D shows that PLB was highly expressed in the INF group
compared with that in the Sham and HF groups. PLB can be phos-
phorylated by PKA at Ser-16, and we observed that the levels of
this protein were unchanged in the INF group and reduced in the
HF group compared with that in the Sham group (Fig. 3 E). The
PLB/pPLB-Ser16 ratio was increased 2-fold in the HF group (Fig. 3
F). The increase in the PLB/pPLB-Ser16 ratio may affect SR Ca2+ re-
uptake by SERCA-2a, contributing to the cardiac dysfunction found
in HF.Discussion
The occurrence of RV dysfunction and failure has been associated
with a poor prognosis after MI, however only few studies have system-
atically addressed RV remodeling following MI [1,32]. Our study was
conducted to investigate RV function following LV MI in rats that
developed or not HF. The rats that showed signs of HF demonstrated
RV dysfunction, whereas the rats that did not show signs of HF had pre-
served RV function and normal inotropic responses in basal conditions
but an impaired response in stress conditions. Thisﬁndingwas associated
with an increase in SERCA-2a that could explain the preserved RV
function under basal conditions.
Recently, clinical studies showed that RV dysfunction is an inde-
pendent predictor of death and of the development of HF following
MI [15,34]. Decreased RV systolic function is a major risk factor for
Fig. 4. Infarct size measured by histological quantiﬁcation in the infarcted group (INF) and
infarcted with signals of heart failure (HF). Five-micrometer sections were cut from the
middle ring at 100-μm intervals and stained with picrosirius red. Infarct perimeter
(fraction of the infarcted LV) was calculated as the average of the perimeter from all slices
and is expressed as a percentage of length.
29A.A. Fernandes et al. / Life Sciences 124 (2015) 24–30death, sudden death, HF, and stroke post-MI [2,34] and decreased RV
diastolic function is also related to poor HF prognosis [19]. However,
these clinical studies often involve patients with other associated
diseases, making difﬁcult the interpretation of these results. The
use of an experimental model of MI allows us to make much more
controlled observations and overcome the limitations associated
with comorbidity observed in clinical studies.
The primary components of HF are increased LVEDP followed by re-
modeling of the right ventricle and pulmonary congestion [4,13,26,34],
and previous studies have shown that these phenomena are correlated
with infarct size [5,24,28,29]. In our study, we only used rats with mod-
erate to large infarct sizes, thus allowing us to evaluate this variable and
study a relatively homogeneous group of animals with respect to HF
development.
The knowledge about the functional and molecular mechanisms
that may explain the RV dysfunction following MI is still poorly
understood.
We demonstrate for the ﬁrst time an increase in SERCA-2a protein
expression in RV of post-MI animals without signs of HF. In fact, an
increased capacity by the SR to load calcium appears to represent a
powerful mechanism underlying the enhanced inotropic reserves con-
ferred by SERCA-2a overexpression [16]. In our study, the SR Ca2+
load was indirectly evaluated via post-rest potentiation measurements,
and the results showed preserved SR Ca2+ loading in the RV of rats that
did not show signs of HF. One hypothetical beneﬁt of high levels of
SERCA-2a protein expression in the heart may be the preservation of
the beta-adrenoreceptor response [14], which undergoes marked de-
sensitization in the failing ventricle due to an exaggerated sympathetic
drive evoked by progressive cardiac deterioration [7]. Our data are con-
sistentwith this hypothesis, because in the presence of isoproterenol – a
beta-adrenergic agonist – force in the RV was preserved in the group
showing high levels of SERCA-2a expression. Strikingly, it has been pro-
posed that enhanced SR Ca2+ uptake has beneﬁcial effects, including
improved systolic and diastolic functions, survival rates and resistance
to HF [7,9]. We found that hemodynamic values such as LVEDP, RVSP,
and RVEDP were similar in the INF and Sham groups, indicating a pre-
served cardiac function in these chambers. These results support the
idea that enhanced SR Ca2+-uptake mediated by increased SERCA-2a
protein expression has beneﬁcial effects. The literature has shown that
in the LV, SERCA-2a overexpression can reverse the contractile abnormal-
ities observed in failing hearts [7,10,16]. Maier et al. [16] found that in-
creases in SERCA-2a protein levels were associated with improved
contraction, relaxation kinetics and rest potentiation of force. These au-
thors attributed their ﬁndings to enhanced SR Ca2+ load and increasesin intracellular Ca2+ due to high expression of the SERCA-2a protein.
The current study also demonstrates that the PLB/pPLB-Ser-16 ratio
was unchanged in the INF group compared with that in the Sham
group. However, this ratio was found to be elevated in the HF group.
This increase in the PLB/pPLB-Ser-16 ratio has been correlated with
decreased Ca2+ sensitivity to SERCA-2a in failing hearts, because the
unphosphorylated form of PLB inhibits SERCA-2a activity, whereas the
phosphorylated form of PLB dissociates from SERCA-2a, leading to in-
creased pumping activity [30]. PLB is themajormembrane proteinwithin
the heart that is phosphorylated in response to beta-adrenergic stimula-
tion. PLB is phosphorylated at serine 16 by the β-adrenergic pathway
and at the threonine 17 primarily by calcium/calmodulin kinase II
[18]. In the present study, we examined changes in the levels of PLB
Ser-16 phosphorylation with a focus on the beta-adrenergic pathway.
It has been demonstrated that reduced PKA-dependent PLB phosphory-
lation during HF may be due to changes at various levels of the beta-
adrenergic signaling pathway [6,11,12]. Decreases in PLB levels and/or
changes in phosphorylation can directly impact SR Ca2+-uptake and
muscle contractility [30], which is consistent with our ﬁnding that the
β-adrenergic response to isoproterenol was impaired in the HF group
but not in the INF group. This phenomenon was most likely mediated
by reduced levels of PLB Ser-16 phosphorylation within the RV of
these rats.
The decreased levels of SR Ca2+ could also have led to the reduc-
tions in post-rest potentiation observed in the HF group, which were
most likely associated with the low levels of PLB Ser-16 phosphory-
lation and its effects on SERCA-2a. These results suggest that PLB-
phosphorylation levels may play a role in the severity of HF.
Conclusion
In summary, the INF group without signs of HF showed preserved
right ventricle contractility in response to increases in extracellular
Ca2+ and isoproterenol and also an increased SERCA-2a protein expres-
sion. In conclusion, increased SERCA-2a protein expression may play a
role in the preservation of RV function post-MI. Therefore, therapeutic
strategies that attempt to increase SERCA-2a protein expression levels
may be useful for the treatment of HF.
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